{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:12:53Z","timestamp":1791666773601,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.carpath.2009.10.003","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T10:04:15Z","timestamp":1258538655000},"page":"8-14","source":"Crossref","is-referenced-by-count":35,"title":["The heart in Fabry's disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Mary N.","family":"Sheppard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2009.10.003_bb0005","first-page":"455","article-title":"Fabry's disease","volume":"44","author":"Adam","year":"2006","journal-title":"Rom.J Intern Med"},{"key":"10.1016\/j.carpath.2009.10.003_bb0010","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00392-002-0848-5","article-title":"The heart in Anderson Fabry disease","volume":"91","author":"Kampmann","year":"2002","journal-title":"Z Kardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0015","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2008.02.050","article-title":"Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results","volume":"51","author":"Linthorst","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0020","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","article-title":"Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996","volume":"105","author":"Applegarth","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.carpath.2009.10.003_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2009.10.003_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.carpath.2009.10.003_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.carpath.2009.10.003_bb0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.carpath.2009.10.003_bb0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a nationwide screening for Anderson\u2013Fabry disease among dialysis patients","volume":"15","author":"Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2009.10.003_bb0055","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson\u2013Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ymgme.2008.03.017","article-title":"Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA)","volume":"94","author":"Schirinzi","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.carpath.2009.10.003_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1399-0004.2003.00050.x","article-title":"Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease","volume":"63","author":"Yang","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.carpath.2009.10.003_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9149(69)90055-1","article-title":"The heart in Fabry's disease. A histochemical and electron microscopic study","volume":"24","author":"Ferrans","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carpath.2009.10.003_bb0085","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.54.5.818","article-title":"Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies","volume":"54","author":"Desnick","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0090","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-8703(80)90060-5","article-title":"The M-mode echocardiogram in Fabry's disease","volume":"100","author":"Bass","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.carpath.2009.10.003_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.2003.tb00222.x","article-title":"Sequelae of storage in Fabry disease\u2014pathology and comparison with other lysosomal storage diseases","volume":"92","author":"Elleder","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.carpath.2009.10.003_bb0100","first-page":"846","article-title":"Cardiac manifestation of Fabry's disease: current knowledge","volume":"50","author":"Palecek","year":"2004","journal-title":"Vnitr.Lek."},{"key":"10.1016\/j.carpath.2009.10.003_bb0105","first-page":"e132","article-title":"Association between polymorphisms of endothelial nitric oxide synthase gene (NOS3) and left posterior wall thickness (LPWT) of the heart in Fabry disease","volume":"122","author":"Rohard","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carpath.2009.10.003_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08035320510028049","article-title":"The right ventricle in Fabry disease","volume":"94","author":"Kampmann","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.carpath.2009.10.003_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease in heterozygous females","volume":"40","author":"Kampmann","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2009.10.003_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000060194","article-title":"A new phenotype of Fabry disease with intermediate severity between the classical form and the cardiac variant","volume":"136","author":"Germain","year":"2001","journal-title":"Contrib Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.carpath.2009.10.003_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1012428009627","article-title":"Cardiac manifestations in Fabry disease","volume":"24","author":"Linhart","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carpath.2009.10.003_bb0135","first-page":"98","article-title":"End-stage cardiac manifestations and autopsy findings in patients with cardiac Fabry disease","volume":"43","author":"Teraguchi","year":"2004","journal-title":"J Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0140","first-page":"705","article-title":"Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy","volume":"18","author":"Tanaka","year":"1988","journal-title":"J Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0145","first-page":"1003","article-title":"An autopsied case of Fabry's disease presenting with parkinsonism and cardiomegaly as a cardinal clinical manifestation","volume":"34","author":"Orimo","year":"1994","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.carpath.2009.10.003_bb0150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.2004.054015","article-title":"Coronary microvascular dysfunction in male patients with Anderson\u2013Fabry disease and the effect of treatment with alpha galactosidase A","volume":"92","author":"Elliott","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.carpath.2009.10.003_bb0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","article-title":"Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease","volume":"172","author":"Chimenti","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson\u2013Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.carpath.2009.10.003_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0175","doi-asserted-by":"crossref","first-page":"W97","DOI":"10.2214\/AJR.08.1201","article-title":"Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy","volume":"192","author":"De","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0180","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2004.035584","article-title":"The natural history of left ventricular systolic function in Anderson\u2013Fabry disease","volume":"91","author":"Shah","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.carpath.2009.10.003_bb0185","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1161\/CIRCULATIONAHA.107.723387","article-title":"Images in cardiovascular medicine. Cryptogenic ventricular arrhythmias and sudden death by Fabry disease: prominent infiltration of cardiac conduction tissue","volume":"116","author":"Frustaci","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/002580249203200315","article-title":"Fabry's disease\u2013a rare cause of sudden death","volume":"32","author":"Sivaloganathan","year":"1992","journal-title":"Med Sci Law"},{"key":"10.1016\/j.carpath.2009.10.003_bb0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000433-199503000-00004","article-title":"Sudden death in elderly women with Fabry's disease","volume":"16","author":"Carter","year":"1995","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0200","first-page":"354","article-title":"Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications","volume":"17","author":"Mignani","year":"2004","journal-title":"J Nephrol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.carpath.2009.10.003_bb0210","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2009.10.003_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2009.10.003_bb0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.carpath.2009.10.003_bb0225","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2005.03.016","article-title":"Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement","volume":"46","author":"Pisani","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.carpath.2009.10.003_bb0230","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0235","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2004.00514.x","article-title":"Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study","volume":"65","author":"Mignani","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.carpath.2009.10.003_bb0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1023\/B:BOLI.0000005658.14563.77","article-title":"Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study","volume":"26","author":"Baehner","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.carpath.2009.10.003_bb0245","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00428-007-0468-6","article-title":"Cellular and tissue localization of globotriaosylceramide in Fabry disease","volume":"451","author":"Askari","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.carpath.2009.10.003_bb0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/MN:32:1:043","article-title":"Enzyme replacement therapy of Fabry disease","volume":"32","author":"Clarke","year":"2005","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0255","unstructured":"Sheppard MN, Cane P, Florio R, Kavantzas N, Close L, Shah J, Lee P, Elliott P. A detailed pathologic examination of heart tissue from three older patients with Anderson\u2013Fabry disease on enzyme replacement therapy. Cardiovasc Pathol [in press]."},{"key":"10.1016\/j.carpath.2009.10.003_bb0260","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carpath.2009.10.003_bb0265","first-page":"1","article-title":"Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement","volume":"448","author":"Schiffmann","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.carpath.2009.10.003_bb0270","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00428-008-0586-9","article-title":"Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients","volume":"452","author":"Keslova-Veselikova","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.carpath.2009.10.003_bb0275","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","article-title":"Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy. Evidence for a better outcome with early treatment","volume":"119","author":"Weidemann","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2009.10.003_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1651-2227.2008.00649.x","article-title":"Early therapeutic intervention in females with Fabry disease?","volume":"97","author":"Hughes","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.carpath.2009.10.003_bb0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2008.00658.x","article-title":"Fabry disease during childhood: clinical manifestations and treatment with agalsidase alfa","volume":"97","author":"Ramaswami","year":"2008","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.carpath.2009.10.003_bb0290","doi-asserted-by":"crossref","DOI":"10.1007\/s00431-009-0937-9","article-title":"Fabry disease in children and the effects of enzyme replacement treatment","author":"Pintos-Morell","year":"2009","journal-title":"Eur J Pediat"},{"key":"10.1016\/j.carpath.2009.10.003_bb0295","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00467-008-0846-6","article-title":"Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes","volume":"23","author":"Kitagawa","year":"2008","journal-title":"Pediatr Nephrol"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880709001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880709001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:24Z","timestamp":1544832024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880709001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1054880709001161"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2009.10.003","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}